AccuraGen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

AccuraGen General Information

Description

Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology circulates deoxyribonucleic acid from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer mutation.

Contact Information

Website
www.accuragen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2720 Zanker Road
  • Suite 240
  • San Jose, CA 95134
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2720 Zanker Road
  • Suite 240
  • San Jose, CA 95134
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AccuraGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Debt - PPP 15-Apr-2020 Completed Generating Revenue
4. Accelerator/Incubator 14-Sep-2016 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Jun-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Feb-2015 $6.9M $6.9M Completed Startup
1. Accelerator/Incubator Completed Startup
To view AccuraGen’s complete valuation and funding history, request access »

AccuraGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology c
Biotechnology
San Jose, CA
15 As of 2024

McLean, VA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AccuraGen Competitors (18)

One of AccuraGen’s 18 competitors is Perthera, a Venture Capital-Backed company based in McLean, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perthera Venture Capital-Backed McLean, VA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
Aurora Biopharma Angel-Backed Cambridge, MA
NexImmune Formerly VC-backed Gaithersburg, MD
Cellerant Therapeutics Venture Capital-Backed Newark, CA
You’re viewing 5 of 18 competitors. Get the full list »

AccuraGen Patents

  • 114

    Total Documents Applications and Grants

  • Total Patents Families

  • 62

    Granted

  • 46

    Pending

  • Expiring in next 12 mo

AccuraGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230234047-A1 Microfluidic detection strip chip and preparation and method thereof Pending 22-Jan-2022
US-20230210561-A1 Fetal intrauterine positioning fixation device and system thereof Pending 01-Jan-2022
US-20230165516-A1 Device for establishing an amniotic cavity access through a mother and method thereof Pending 28-Nov-2021
US-20240117443-A1 Gene expression and cell-free dna methods and systems for disease detection Pending 23-Jun-2021
US-20230348986-A1 Methods and systems for sample normalization Pending 11-Nov-2020 C12Q1/6883
To view AccuraGen’s complete patent history, request access »

AccuraGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AccuraGen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
QB3 Accelerator/Incubator
Detong Capital Venture Capital Minority
Junson Capital Asset Manager Minority
Nan Fung Life Sciences Venture Capital Minority
Pivotal Life Sciences Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

AccuraGen FAQs

  • When was AccuraGen founded?

    AccuraGen was founded in 2013.

  • Where is AccuraGen headquartered?

    AccuraGen is headquartered in San Jose, CA.

  • What is the size of AccuraGen?

    AccuraGen has 15 total employees.

  • What industry is AccuraGen in?

    AccuraGen’s primary industry is Biotechnology.

  • Is AccuraGen a private or public company?

    AccuraGen is a Private company.

  • What is AccuraGen’s current revenue?

    The current revenue for AccuraGen is .

  • How much funding has AccuraGen raised over time?

    AccuraGen has raised $46.9M.

  • Who are AccuraGen’s investors?

    QB3, Detong Capital, Junson Capital, Nan Fung Life Sciences, and Pivotal Life Sciences are 5 of 10 investors who have invested in AccuraGen.

  • Who are AccuraGen’s competitors?

    Perthera, Allogene Therapeutics, Aurora Biopharma, NexImmune, and Cellerant Therapeutics are some of the 18 competitors of AccuraGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »